fleroxacin has been researched along with Ischemia in 1 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miglioli, PA | 1 |
| Kafka, R | 1 |
| Bonatti, H | 1 |
| Fraedrich, G | 1 |
| Allerberger, F | 1 |
| Schoeffel, U | 1 |
1 other study available for fleroxacin and Ischemia
| Article | Year |
|---|---|
Fleroxacin uptake in ischaemic limb tissue.
Topics: Adipose Tissue; Animals; Anti-Infective Agents; Bone and Bones; Diffusion; Extremities; Female; Fler | 2001 |